MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Under three seconds: Objective speech markers of ataxia in Multiple Sclerosis

G. Noffs, F. Boonstra, S. Kolbe, A. Evans, H. Butzkeuven, T. Perera, A. Walt, A. Vogel (Melbourne, Australia)

Meeting: 2018 International Congress

Abstract Number: 657

Keywords: Cerebellum, Dysarthria, Multiple sclerosis(MS)

Session Information

Date: Sunday, October 7, 2018

Session Title: Ataxia

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: To examine the relationship between objective markers of speech motor control, disease severity and ataxia.

Background: Mild dysarthria is a common symptom of Multiple Sclerosis and frequently co-occur with limb tremor and ataxia. Yet, the relationship between speech characteristics, MS disease severity and cerebellar manifestations (such as tremor) is poorly understood.

Methods: Participants with upper limb tremor and limb ataxia were recruited along with non-tremor controls. The Scale for Assessment and Rating of Ataxia (SARA) and the Expanded Disability Status Scale (EDSS) score were determined by a neurologist. Acoustic analysis of speech was used in three seconds-long speech samples to investigate: 1) stability of vocal pitch, in sustained utterance of the vowel /a/; 2) stability of loudness, in the same vocal task and 3) alternating motion rate (speech diadochokinesis, /pa/ta/ka/ used as token). After adjustment for multiple comparisons, p<0.016 was considered for statistical significance.

Results: 33 participants with Multiple Sclerosis and upper limb tremor (46.9±12.3years, 75% female, EDSS=3.8 IQ=2.5) were matched with 33 people with Multiple Sclerosis but without tremor (47.7±10years, 75% female, EDSS=3.6 IQ=3.5). Diadochokinetic rate was 0.62 syllable/second slower in the tremor group (95%CI=0.17 to 1.07, p=0.007) and inversely correlated with SARA (Spearman’s rho=.612, p<0.001) and EDSS scores (rho=.370, p=0.002). Stability of pitch inversely correlated with SARA (rho=0.555, p<0.001) and EDSS scores (rho=0.404, p=0.001) but no significant differences between groups were observed. No significant relation between loudness stability values and other variables was observed.

Conclusions: automated analysis of speech can be used to assess cerebellar disfunction in short samples of speech from people with Multiple Sclerosis. Longitudinal studies are needed to understand the potential for monitoring disease progression.

To cite this abstract in AMA style:

G. Noffs, F. Boonstra, S. Kolbe, A. Evans, H. Butzkeuven, T. Perera, A. Walt, A. Vogel. Under three seconds: Objective speech markers of ataxia in Multiple Sclerosis [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/under-three-seconds-objective-speech-markers-of-ataxia-in-multiple-sclerosis/. Accessed May 18, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/under-three-seconds-objective-speech-markers-of-ataxia-in-multiple-sclerosis/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley